Low-Dose Naltrexone (LDN) is quickly becoming the preferred treatment for a wide range of Auto-Immune and chronic diseases including MS, Crohn's, IBS, Colitis, Cancer, Autism, Rheumatoid Arthritis, ME/CFS, Fibromyalgia, and more.
Here is your opportunity to establish your company as a key player in the worldwide LDN community and take advantage of the growing momentum behind its efficacy.
The LDN AIIC 2019 Conference is the only LDN focused event in the world. Here, the world’s leading experts and practitioners discuss the latest findings, experiences and case studies while suppliers and providers showcase their latest products and services.
The goal of the conference is to raise awareness of LDN among healthcare professionals and encourage its use in treating a growing number of chronic diseases by highlighting compelling examples and real-world results.